Agilon Health, Inc. (NYSE:AGL) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Analyst consensus is “Hold”: Of 14 brokerages, seven recommend holding Agilon Health, five recommend buying, and two recommend selling. The average 12-month price target is $97.70.
• Recent ratings were mixed but generally constructive, with Benchmark raising its target to $140 and Citigroup upgrading the stock from “sell” to “neutral.”
• Agilon Health reported quarterly EPS of $1.04, well above the $0.14 consensus estimate, while revenue of $1.49 billion also exceeded expectations; however, analysts expect a full-year loss of $2.11 per share.

Shares of Agilon Health, Inc. (NYSE:AGL - Get Free Report) have been given an average recommendation of "Hold" by the fourteen research firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, seven have given a hold rating and five have assigned a buy rating to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $97.70.

Several brokerages have recently commented on AGL. Robert W. Baird set a $116.00 price target on shares of Agilon Health in a research report on Thursday, August 6th. Barclays set a $111.00 price objective on Agilon Health and gave the company an "equal weight" rating in a report on Thursday, August 6th. Benchmark restated a "buy" rating and set a $140.00 price objective (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Citigroup raised Agilon Health from a "sell" rating to a "neutral" rating and increased their target price for the stock from $105.00 to $115.00 in a report on Monday, August 10th. Finally, Truist Financial set a $112.00 target price on Agilon Health and gave the stock a "hold" rating in a research report on Thursday, August 6th.

Hedge Funds Weigh In On Agilon Health

A number of hedge funds have recently added to or reduced their stakes in AGL. Allworth Financial LP acquired a new stake in Agilon Health during the 2nd quarter worth about $114,000. Proficio Capital Partners LLC acquired a new position in shares of Agilon Health in the second quarter worth about $210,000. Bank of New York Mellon Corp boosted its holdings in shares of Agilon Health by 9.5% in the second quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company's stock worth $3,787,000 after buying an additional 3,074 shares during the period. The Manufacturers Life Insurance Company purchased a new position in shares of Agilon Health in the second quarter worth approximately $355,000. Finally, Integrated Wealth Concepts LLC purchased a new position in shares of Agilon Health in the second quarter worth approximately $384,000.

Agilon Health Trading Down 1.0%

AGL opened at $92.67 on Friday. Agilon Health has a 12-month low of $7.48 and a 12-month high of $133.04. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08. The stock has a market capitalization of $1.56 billion, a PE ratio of -6.49 and a beta of 3.02. The firm's fifty day moving average price is $100.20 and its 200 day moving average price is $68.94.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.90. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. As a group, research analysts expect that Agilon Health will post -2.11 EPS for the current fiscal year.

Agilon Health Company Profile

Agilon Health NYSE: AGL is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.